MedPath

Clinical evaluation of Contrast Enhanced Breast CT to improve Staging and treatment follow up in women with breast cancer

Recruiting
Conditions
breast cancer
Mamma carcinoma
10006291
Registration Number
NL-OMON54169
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
413
Inclusion Criteria

- Women >18 years old
- Diagnoses of breast cancer
- Scheduled for a pre-surgery staging contrast enhanced breast MRI
- Eligible for primary systemic therapy

Exclusion Criteria

- Women with suspected or confirmed pregnancy
- Women with prior breast cancer
- Women who are breastfeeding
- Women who are very frail and unable to cooperate
- Women who cannot give informed consent
- Contra indication of iodine contrast
- Contra indication for irradiation (i.e. genetic mutation that predispose to
breast cancer)
- Male subjects

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath